Kamal Batra
Internal Medicine · Brooklyn, NYNPI 1245279462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,968, 2.9 times the $2,074 reported in 2019. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $79.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi-aventis U.S. LLC$742
- Corcept Therapeutics$730
- Abbott$685
- Dexcom, Inc.$627
- Novo Nordisk$562
- plus $4K from 21 others
What the payments were for
- Speaking & faculty fees$7308%
- Food & beverage$8,84892%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $2,296 |
| Sanofi-aventis U.S. LLC | 6 | $742 |
| Corcept Therapeutics | 1 | $730 |
| Abbott | 5 | $685 |
| Dexcom, Inc. | 9 | $627 |
| Novo Nordisk | 9 | $562 |
| Amgen | 6 | $463 |
| Bayer | 20 | $458 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $372 |
| Boehringer Ingelheim | 3 | $370 |
| Cequr Corporation | 1 | $277 |
| Kowa Pharmaceuticals America, Inc. | 7 | $231 |
| E.r. Squibb & Sons, L.L.C. | 2 | $211 |
| Amarin Pharma, Inc. | 3 | $207 |
| AbbVie | 2 | $180 |
| Medtronic(2 entities) | 2 | $160 |
| Verona Pharma, Inc. | 2 | $147 |
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Advanced Oxygen Therapy Inc. | 1 | $122 |
| GSK | 1 | $121 |
| Ascendis Pharma Endocrinology Inc | 1 | $120 |
| Johnson & Johnson | 1 | $119 |
| Exact Sciences | 2 | $47 |
| Tandem Diabetes Care, Inc. | 1 | $32 |
| Tactile Systems Technology Inc | 1 | $27 |
| Shield Therapeutics Inc | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$743
- TZIELD$742
- Korlym$730
- FARXIGA$472
- DEXCOM G7 GSS (161)$394
- DEXCOM STELO GLUCOSE BIOSENSOR$394
- FreeStyle Libre Pro$375
- JARDIANCE$370
- FREESTYLE LIBRE 3$310
- CeQur Simplicity$277
- AIRSUPRA$250
- LOKELMA$249
- FASENRA$249
- Repatha$150
- Kerendia$140
- TEPEZZA$134
- Wegovy$125
- GVOKE HYPOPEN$125
- Auvelity$125
- HawkOne$125
How this compares
$9,584 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Jesi RamoneBrooklyn$627K
- Manish ParikhBrooklyn$236K
- Samuel UterBrooklyn$136K
- David DoveEast Hampton$12.3M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.